ResMed Inc. (RMD.XA)
Cboe AU - Cboe AU Real-time price. Currency in AUD
Add to watchlist
At close: 03:59PM AEST
| Previous close | 31.15 |
| Open | 31.53 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 31.31 - 31.59 |
| 52-week range | 21.14 - 34.28 |
| Volume | |
| Avg. volume | 483,376 |
| Market cap | N/A |
| Beta (5Y monthly) | 0.64 |
| PE ratio (TTM) | 16.46 |
| EPS (TTM) | 1.90 |
| Earnings date | 01 Aug 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Zacks3 Reasons Growth Investors Will Love ResMed (RMD)
ResMed (RMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.
ZacksTeleflex's (TFX) Urolift Drives Market Share, Macro Woes Stay
The commercialization of Teleflex's (TFX) UroLift in Japan has been a significant step toward making this therapy more broadly available to men suffering from BPH.
ZacksBioLife (BLFS) Progresses in Cell & Gene Therapy With CryoCase
BioLife's (BLFS) latest product, CryoCase, is compatible with various downstream processing systems, including its own Signata CT-5.
© 2024 Yahoo. All rights reserved.